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A new biomimetic material for artificial blood vessel with in situ catalytic generation of nitric oxide (NO) was prepared in this 
study. Organoselenium immobilized polyethyleneimine as NO donor catalyst and sodium alginate were alternately loaded onto 
the surface of electrospun polycaprolactone matrix via electrostatic layer-by-layer self-assembly. This material revealed sig-
nificant NO generation when contacting NO donor S-nitrosoglutathione (GSNO). Adhesion and spreading of smooth muscle 
cells were inhibited on this material in the presence of GSNO, while proliferation of endothelial cells was promoted. In vitro 
platelet adhesion and arteriovenous shunt experiments demonstrated good antithrombotic properties of this material, with in-
hibited platelet activation and aggregation, and prevention of acute thrombosis. This study may provide a new method of im-
proving cellular function and antithrombotic property of vascular grafts. 
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Cardiovascular diseases as coronary artery occlusion are 
now a serious threat to human health worldwide [1]. One of 
the effective treatments of these diseases is vascular graft 
implantation, and an inner surface with antithrombotic 
properties and rapid endothelialization is the key to success. 
As a potent vasodilator and antiplatelet agent [24], ni-
tric oxide (NO) has unique functions [5]. It can prevent mi-
crobial growth [6], enhance wound healing [79], and in-
hibit adhesion and activation of platelets [1013] and prolif-
eration of smooth muscle cells (SMCs) [14]. The perfect 
thromboresistance of the natural endothelium has been 
partly attributed to the low but continuous production of NO 
in this layer [15,16]. Endothelial cells (ECs) that line the 
inner walls of healthy blood vessels produce NO at an esti-
mated flux of 0.5×10−104.0×10−10 mol cm−2 min−1[17], 
which plays an important regulatory role on the physiology 
and function of the cardiovascular system [18]. This sus-
tained NO-releasing can reduce the occurrence of vascular 
restenosis [13,19,20]. Therefore, vascular grafts that could 
release or generate NO in situ will possibly solve the prob-
lem of thrombosis and intimal hyperplasia of small-diame- 
ter vascular grafts [21]. 
In recent years, some researches have been done in the 
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field of NO-releasing polymers [5,2224]. Some NO-  
releasing materials have been developed by fixing NO do-
nors such as N-diazeniumdiolate or S-nitrosothiol (RSNO) 
into the polymer by physical mixing or chemical attachment 
[25,26]. These materials showed excellent anti-thrombosis 
property, but had problems in burst release, limited storage 
and inevitable cytotoxicity [27]. 
There are various kinds of RSNO in peripheral blood, 
such as S-nitrosoalbumin (Alb-SNO) and S-nitrosogluta- 
thione (GSNO) [28,29], and a selenium-containing enzyme 
glutathione peroxidase has the effect on catalyzing NO gen-
eration from RSNO [30,31]. Because of the constant content 
of RSNO, this endogenous NO donor can be utilized to ful-
fill good anticoagulant property by long-term in situ NO 
generation. 
To simulate the function of native blood vessel, we pro-
posed to modify the surface of vascular graft with orga-
noselenium catalyst to generate NO stably from endogenous 
NO donor RSNO. As a facile surface coating technique, 
layer-by-layer self-assembly has many advantages such as 
simple procedures and adaptability to various substrates 
[32], and has increasingly been used to immobilize biom-
acromolecules onto the vascular prostheses and tissue engi-
neering scaffolds to improve their hemocompatibility or 
cytocompatibility [3338].  
In this study, organoselenium immobilized polyeth-
yleneimine and sodium alginate were deposited onto the 
surface of electrospun polycaprolactone matrix via lay-
er-by-layer self-assembly. In vitro NO generation was per-
formed to test the catalyzing capability of the material. The 
bioactivity of the modified material was evaluated by adhe-
sion and spreading of SMCs and proliferation of ECs. Fi-
nally, the antithrombotic properties of the material were 
observed through platelet adhesion and arteriovenous shunt 
experiments. 
1  Materials and methods  
1.1  Materials 
Polycaprolactone (PCL, Mw 80 kD) was purchased from 
Solvay Interox Ltd, UK. Polyethyleneimine (PEI, Mw 25 kD) 
and polydiallyldimethylammonium chloride (PDDA, Mw 
100200 kD) were obtained from Sigma-Aldrich. 2-(N- 
cyclohexylamino)-ethanesulfonic acid (CHES), sodium 
alginate (AlgNa) and glutathione (GSH) were purchased 
from Beijing Dingguo Biotech Co. Ltd. MTT was obtained 
from Lianxing Biotechnology Inc. DiI was purchased from 
Invitrogen. Griess Assay Kit was purchased from Beyotime 
Institute of Biotechnology. 
1.2  Fibrous scaffold preparation 
PCL fibrous scaffolds (tube for arteriovenous shunt experi-
ment and film for all other parts) were prepared by electro-
spinning. PCL was dissolved in chloroform/methanol (5:1 
v/v) to a concentration of 12% (w/v). Electrospinning was 
carried out at a flow rate of 2 mL h1 and a voltage of 18 kV. 
For film matrix, fibers were collected on an aluminum foil 
on a rotating mandrel with a collecting distance of 20 cm. 
For tubular matrix, fibers were deposited on a rotating 
stainless steel mandrel with a diameter of 2.0 mm at a dis-
tance of 18 cm. 
1.3  Loading of organoselenium catalyst via layer-by- 
layer self-assembly 
3,3′-diselenodipropionic acid (SeDPA) and organoselenium 
immobilized polyethyleneimine (SePEI) were synthesized 
according to reported method [39].  
Polyelectrolytes were dissolved to make 1 mg mL1 solu-
tions: PDDA in CHES while SePEI and AlgNa in distilled 
water. Self-assembly was proceeded by immersing the film 
alternately into polycation (SePEI or PDDA) and polyanion 
(AlgNa) solutions for 10 min and washing by distilled water 
after each step. A PDDA/AlgNa bilayer was loaded as a 
precursor layer, and then SePEI and AlgNa were deposited 
until a certain number of bilayers ((SePEI/AlgNa)n) were 
reached. Films prepared using PEI and AlgNa ((PEI/   
AlgNa)n) were used as control. For tubular matrix, the poly-
electrolyte solutions flowed through the tube at a very slow 
rate controlled by constant-flow pumps. 
1.4  Characterization of PCL scaffold and polyelectro-
lytes loaded film 
1.4.1  SEM observation  
The micromorphology of PCL scaffold and polyelectrolytes 
loaded films was observed by scanning electron microscope 
(SEM; QUANTA 200; FEI, USA) with an acceleration 
voltage of 15 kV. Samples were gold-coated before SEM. 
1.4.2  Contact angle measurement  
To measure water contact angle, self-assembly was done on 
a film coated on a glass slide. Contact angle was measured 
on a HARKE SPCA instrument (Beijing, China) after each 
layer was deposited and dried. The values were determined 
by averaging the measurements at five different positions 
(n=5). 
1.4.3  Selenium content measurement  
Selenium (Se) content on the film was measured by an 
atomic absorption spectrophotometer (TAS-990, Beijing 
Purkinje General Instrument Co. Ltd., Beijing, China) after 
each SePEI/AlgNa bilayer was deposited. 
1.4.4  Stability test of loaded catalyst  
PCL-(SePEI/AlgNa)5 film was immersed into PBS and kept 
at 37°C under static condition. 5 mL sample PBS was re-
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moved every five days, and 5 mL fresh PBS was added. The 
content of shed Se in sample PBS was scanned by atomic 
absorption spectrophotometer. 
1.5  In vitro catalytic NO generation determination 
GSNO was synthesized according to literature [40] and 
slightly modified. 300 μL PBS containing 200 μmol L1 
GSNO, 200 μmol L1 GSH and 2 nmol L1 EDTA was 
added onto each film (PCL-(SePEI/AlgNa)5, PCL-(SePEI/ 
AlgNa)10 and PCL-(SePEI/AlgNa)15) in 48-well plates and 
the plates were kept in dark at 37°C. At certain time points 
(2, 4, 6 and 8 h), accumulative NO generation was meas-
ured using Griess Assay Kit. Tissue culture polystyrene 
plate (TCPS) and PCL-(PEI/AlgNa)n films were used as 
controls. 
1.6  Fibroblast proliferation 
For cellular experiments (section 1.6–1.9), sample films 
were cut into circular pieces, put into 48-well plates and 
sterilized under ultraviolet radiation overnight. 
3T3 fibroblasts were seeded at a concentration of 1×104 
per film in 48-well plates and incubated at 37°C. The me-
dium was refreshed every two days and the proliferation of 
cells was tested at day 1, 3 and 5 by MTT assay. 
1.7  SMCs adhesion 
Human SMCs were dyed by DiI before seeding onto each 
film in 48-well plates at a density of 2×104 per well with 
200 μmol L1 GSNO and 200 μmol L1 GSH for 2 h at 37°C. 
The adhered cells were fixed in 4% paraformaldehyde for 
10 min and observed with inverted fluorescence micro-
scope.   
1.8  SMCs spreading 
5×104 SMCs with 200 μmol L1 GSNO and 200 μmol L1 
GSH were seeded onto each film and cultured for 4 h at 
37°C. The cells were then stained with FITC-labeled phal-
loidin and observed under confocal laser scanning micros-
copy (CLSM; TCS SP5; Leica, Germany), or fixed in 2.5% 
glutaraldehyde overnight and dehydrated in gradient ethanol 
for SEM observation. 
1.9  ECs proliferation 
2×103 human umbilical vein endothelial cells were seeded 
onto each film in 48-well plates with 200 μmol L1 GSNO 
and 200 μmol L1 GSH and cultured at 37°C. 6 μL of      
20 mmol L1 GSNO and 3 μL of 100 mmol L1 GSH were 
added every 12 h and the medium was replaced every 24 h. 
After 1, 3, 5 days, the proliferation of cells was determined 
by MTT method. 
1.10  In vitro platelet adhesion 
Human platelet rich plasma was obtained from Tianjin 
Blood Center. Platelet suspension (l07 mL1) was added 
onto each film with 200 μmol L1 GSNO and 200 μmol L1 
GSH in 48-well plate and incubated at 37°C under static 
condition for 1 h. Then the films were washed twice with 
PBS to remove unattached platelets, and fixed and dehy-
drated for SEM observation.  
1.11  Arteriovenous shunt (AV-shunt) experiment 
Arteriovenous shunt (AV-shunt) experiment was performed 
using tubular grafts on male Sprague Dawley rats to inves-
tigate the blood compatibility of the modified grafts. All 
animal procedures were approved by the Animal Care 
Committee in Nankai University. The connected grafts of 
PCL and PCL-(SePEI/AlgNa)5 were pretreated by heparin 
for 30 min. Rats were anesthetized by abdominal injection 
of 10% chloral hydrate (3 mL kg1). Heparin (100 units kg1) 
was administered as an anti-coagulant agent. After incision 
of abdominal skin and isolation of abdominal aorta and in-
ferior vein, the series of grafts was connected into the cir-
culation using indwelling needles. After circulation of 1 h, 
the circuit was perfused with physiological saline and fixed 
with 4% paraformaldehyde for 4 h for stereomicroscope 
observation or fixed in 2.5% glutaraldehyde overnight and 
dehydrated through gradient ethanol for SEM observation. 
1.12  Statistical analysis 
All experiments were performed using six samples (n=6) 
and quantitative results were presented as mean±standard 
deviation (SD) unless otherwise specified. Statistical signif-
icance analysis was determined using TTEST. Significance 
was established by a value of P<0.05. 
2  Results and discussion 
2.1  Characterizations of prepared materials 
Uniformly distributed smooth PCL electrospun fibers with 
diameters in the range of 100400 nm (Figure 1G) were 
obtained under the condition in this study. After loading of 
polyelectrolytes, there were slight changes in the morphol-
ogy of the fibers. Fibers of (SePEI/AlgNa)n films were 
clearer than those of (PEI/AlgNa)n films, while the latter 
exhibited some extent of adhesion and conglutination. This 
could be possibly explained by the fact that the derivation of 
PEI with SeDPA reduced the viscosity of its solution and 
thus resulted in a clearer micromorphology. 
Water contact angle of the prepared film was measured 
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Figure 1  Micromorphology of prepared films. A, (PEI/AlgNa)5. B, (SePEI/AlgNa)5. C, (PEI/AlgNa)10. D, (SePEI/AlgNa)10. E, (PEI/AlgNa)15. F, 
(SePEI/AlgNa)15. G, PCL. (Scale bar = 50 μm in low magnification images and 10 μm in high magnification images). 
to determine the hydrophilicity/hydrophobicity and make an 
analysis of the assembly process. The contact angle was 
103°5° when polycation SePEI was the outermost layer 
and 93°3° for polyanion AlgNa (Figure 2). The zigzag 
curve of contact angle proved the alternate adsorption of the 
polyelectrolytes. 
To have a quantitative analysis of the assembly, atomic 
absorption spectrometry was used to get the exact content of 
Se loaded on the film (Figure 3). The content of Se in-
creased rapidly for the first three bilayers but relatively 
slowly for the next five bilayers, and reached a maximum 
amount of 1.53103 μg L1 cm2 on each piece of film (di-
ameter 1 cm) after the eighth bilayer. The content decreased 
at the ninth bilayers a bit, probably due to self-healing of 
electrostatic assembly film, which is that the surface charge 
density may reach a constant after several depositions [41]. 
Retention rate of Se element on the film was determined 
to evaluate the stability of loaded Se catalyst. Retention rate 
was calculated as the ratio of Se content on the film after 
certain days immersed in PBS to the original content on the 
film. The result showed an acceptable stability of loaded 
catalyst under static condition, with a Se retention rate of 
80% after immersing in PBS for up to 35 days. 
2.2  Catalytic NO generation 
Results of in vitro catalytic NO generation were shown in 
Figure 4. With EDTA in the system, interfering catalytic 
decomposition of GSNO by transient metal ions such as Cu 
(II) could be eliminated. As illustrated in Figure 4A, B and 
C, catalyst-loaded materials ((SePEI/AlgNa)n) could obvi-
ously accelerate the release of NO from its donor GSNO. 
Therefore, materials constructed by the method in this study 
are expected to fulfill in situ NO generation when contact- 
 
Figure 2  Water contact angles of (SePEI/AlgNa)n film with different 
numbers of layers of polyelectrolytes. Odd numbers signify SePEI as the 
outermost layer and even numbers signify AlgNa. 
 
Figure 3  Se content on (SePEI/AlgNa)10 film after each loaded bilayer.
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Figure 4 (color online)  In vitro catalytic NO generation by films with different numbers of loaded bilayers. A, (SePEI/AlgNa)5. B, (SePEI/AlgNa)10. C, 
(SePEI/AlgNa)15. D, collected results of (SePEI/AlgNa)n. (Data expressed as meanSD, n=6). 
ing peripheral blood, which contains a certain amount of 
NO donors. 
By comparing results of different groups (Figure 4D), it 
could be seen that the catalyzing ability of the material was 
increased with a rise in the number of bilayers loaded. The 
amount of Se catalyst on the film was proportional to the 
number of loaded bilayers, and therefore this approach 
would enable a controllable catalyzing capability and NO 
generation. 
2.3  Cellular behavior evaluation 
Proliferation of 3T3 fibroblast was tested using MTT assay 
to evaluate the cytocompatibility of the materials. Figure 5 
shows that the cell number was higher on PCL- 
(SePEI/AlgNa)5 film than that on PCL-(PEI/AlgNa)5 or 
control groups (PCL and TCPS). This result suggested that 
the polycation SePEI and polyanion AlgNa possess satis-
factory cellular compatibility, and their contribution to the 
increased hydrophilicity of the film surface might be the 
reason of a higher cell amount. 
The effects of catalytically generated NO on adhesion 
and spreading of SMCs were evaluated. The adhesion of 
SMCs was reduced on PCL-(SePEI/AlgNa)5 film, demon-
strated by a lower cell number (Figure 6). Meanwhile, ob-
servation of cell morphology under SEM and CLSM dis-
covered that the spreading of SMCs was inhibited on cata- 
lyst-loaded film (Figure 7). SMCs exhibited full spreading  
 
Figure 5  Cytocompatibility of (SePEI/AlgNa)5 film. (Data expressed as 
meanSD, n=6). 
on PCL or PCL-(PEI/AlgNa)5 film, but shrunk shape on 
PCL-(SePEI/AlgNa)5 film. Since SMCs have been indicated 
as the major participant cells in intimal hyperplasia and 
restenosis, and NO is reported to suppress the adhesion and 
proliferation of SMCs [20], materials constructed in this 
study would be effective in reducing intimal hyperplasia by 
catalyzing long-term in situ NO generation. 
ECs proliferation on the films was monitored to observe 
the effect of catalyst-loaded film on ECs growth. It could be 
seen from the result (Figure 8) that the cell number on  
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Figure 6 (color online)  SMCs adhesion on (SePEI/AlgNa)5 film. A1, (SePEI/AlgNa)5, 10. A2, (SePEI/AlgNa)5, 20. B1, (PEI/AlgNa)5, 10. B2, 
(PEI/AlgNa)5, 20. C, cell density. 
 
Figure 7 (color online)  SMCs spreading on (SePEI/AlgNa)5 film. A, PCL. B, (PEI/AlgNa)5. C, (SePEI/AlgNa)5. 1: CLSM images; 2: SEM photos. (Scale 
bar = 25 μm in CLSM images and 50 μm in SEM images). 
PCL-(SePEI/AlgNa)5 film was greater compared to those on 
PCL and PCL-(PEI/AlgNa)5 films. ECs play significant 
functions in blood vessels as preventing thrombosis and 
modulating proliferation of SMCs, and thus rapid endothe-
lialization has become one concern in vascular graft con-
struction. NO was reported to stimulate the proliferation of 
ECs [20], therefore, surface modification method proposed 
in this study might be helpful in promoting endothelializa-
tion of vascular grafts. 
2.4  Evaluation of antithrombotic properties  
The antithrombotic properties of NO generating grafts con- 
structed in this study were characterized by in vitro platelet 
adhesion and AV-shunt experiments. SEM graphs in Figure 9 
 
Figure 8  Proliferation of ECs on (SePEI/AlgNa)5 film. (Data expressed 
as meanSD, n=6). 
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show that the quantity of adhered platelets was less on sur-
faces of PCL-(SePEI/AlgNa)5 film compared to those on the 
controls. 
To evaluate the property of the modified graft to prevent 
acute thrombosis, tubular PCL-(SePEI/AlgNa)5 graft was 
exposed to blood flow for 1 h in AV-shunt experiment. Ste-
reomicroscopy showed that the luminal surface of the grafts 
was clean and smooth without visible thrombi (Figure 10B1). 
SEM images showed that abundant platelets adhered on 
PCL grafts (Figure 10A2) whereas few platelets were ob-
served on PCL-(SePEI/AlgNa)5 graft (Figure 10B2), sug-
gesting an inhibitory property of the NO generating 
PCL-(SePEI/AlgNa)5 surface on platelet adhesion. As adhe-
sion and activation of platelets is a critical and starting step 
in thrombus formation, the catalyst-loaded grafts might re-
duce the risk of acute thrombosis and possess a better he-
mocompatibility. 
3  Conclusion 
In this study, we proposed a novel method of improving the 
hemocompatibility and bioactivity of artificial blood vessel 
by loading organoselenium catalyst onto the inner surface of 
electrospun tubular graft. Catalyst-loaded material showed 
significant in situ NO generation and the catalyzing capabil-
ity could be adjusted through the number of polyelectrolyte 
layers loaded. Modified films possessed good cellular com-
patibility, and could inhibit adhesion and spreading of 
SMCs and promote proliferation of ECs. Satisfactory an- 
tithrombotic properties of these NO generating materials 
were proven by reduced platelet adhesion and prevention of 
acute thrombosis. This study provides a potential approach 
of constructing vascular grafts with improved antithrom-
botic property and desirable biological functions.  
 
 
Figure 9  Platelet adhesion on (SePEI/AlgNa)5 film. A, PCL. B, (PEI/AlgNa)5. C, (SePEI/AlgNa)5. (Scale bar = 50 μm). 
 
Figure 10 (color online)  Hemocompatibility of (SePEI/AlgNa)5 graft. A, PCL. B, (SePEI/AlgNa)5 . 1: stereomicroscope images; 2: SEM photos. (Scale bar 
= 50 μm in SEM images). 
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